Spinout OrganOx completes European clinical trial

21st March 2016

Organox has completed the European multi-center trial of its Organox metra device, which improves the success of liver transplantation.

The study, the world’s first multi-center randomised clinical trial to compare the benefits of warm liver perfusion with the currently accepted practice of cold storage, comprised 220 liver transplants at 7 European centres.

OrganOx CEO, Dr Les Russell commented:  “This is a significant milestone for OrganOx. Study recruitment completed 3 months earlier than expected which is a testament to the commitment of the transplant centres and their experiences with our device. “

For more information, please visit OrganOx website here: http://www.organox.com/

Press release sign up